Herpes Labialis Treatment Market to Garner Brimming Revenues by 2027: Novartis AG, Valeant Pharmaceuticals International Inc., Pfizer Inc., Abbott Laboratories
Attributed to rising penetration of generics and innovations in disease treatment, the US$ 869.3 Mn global herpes labialis treatment market is anticipated to expand at a CAGR of 4.6% over 2017-2027, attaining a value worth US$ 1,358.7 Mn by 2027 end. Over a 10-year forecast period, the demand for herpes labialis treatment is likely to be driven by growing instances of viral infection worldwide and evolution of drug types and modes of action. Moreover, strategic M&A activities among leading industry...
View full press release